scholarly journals A prospective phase II trial of carboplatin (CBDCA) and nab-paclitaxel (nabPTX) for advanced non-small cell lung cancer (NSCLC) with interstitial lung disease (ILD)

2019 ◽  
Vol 30 ◽  
pp. v647
Author(s):  
T. Harada ◽  
H. Asahina ◽  
S. Oizumi ◽  
K. Takamura ◽  
M. Harada ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Interstitial Lung Disease ◽  
Small Cell Lung Cancer ◽  
Lung Disease ◽  
Phase Ii ◽  
Cell Lung Cancer ◽  
Phase Ii Trial ◽  
Small Cell ◽  
Small Cell Lung ◽  
Prospective Phase

scholarly journals Phase II study of nab‐paclitaxel + carboplatin for patients with non‐small‐cell lung cancer and interstitial lung disease

2019 ◽  
Vol 110 (12) ◽  
pp. 3738-3745 ◽  
Author(s):  
Hirotsugu Kenmotsu ◽  
Kiyotaka Yoh ◽  
Keita Mori ◽  
Akira Ono ◽  
Tomohisa Baba ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Interstitial Lung Disease ◽  
Small Cell Lung Cancer ◽  
Lung Disease ◽  
Phase Ii ◽  
Cell Lung Cancer ◽  
Phase Ii Study ◽  
Small Cell ◽  
Small Cell Lung
Sign in / Sign up

Export Citation Format

Share Document